Published in Biotech Law Weekly, May 5th, 2006
Study 1: Research from Brazil has reported that iron overload does not affect hepatitis C virus (HCV) genotype and response to interferon and ribavirin therapy.
"The objective of the present study was to determine the presence of hepatic iron overload in patients with chronic HCV infection and to correlate it with histologic alterations, HCV genotype and response to therapy," wrote R.M. Souza and colleagues, Universidade Federal da Bahia.
They continued, "Liver tissue samples from 95 patients with chronic hepatitis C were divided into two...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2006-05-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.